This, together with our previous study on a tRF derived from Chinese yew, which suppresses ovarian cancer by targeting the oncogene TRPA1 (31), raises the hypothesis that tRFs derived from non-pathogenic E. coli might also function via an RNA interference (RNAi) pathway. This evidence concerns the gene TRPA1 and ovarian cancer.